The enhanced behavior correlated with a significant rise in c-Fos expression within tyrosine hydroxylase-positive (TH+) neuronal populations in the ventral tegmental area and substantia nigra pars compacta, suggesting R-VNS may enhance therapeutic outcomes for diseases like Parkinson’s by more effectively engaging the dopaminergic pathways. This evidence concerns the gene FOS and Parkinson disease.